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Abstract
An individualized risk prediction model that dynamically updates the probability of
a clinical event from a specific cause is valuable for physicians to be able to optimize
personalized treatment strategies in real-time by incorporating all available information
collected over the follow-up. However, this is more complex and challenging when com-
peting risks are present, because it requires simultaneously updating the overall survival
and the cumulative incidence functions (CIFs) while adjusting for the time-dependent
covariates and time-varying covariate effects. In this study, we developed a landmark
proportional subdistribution hazards (PSH) model and a more comprehensive super-
model by extending the landmark method to the Fine-Gray model. The performance
of our models was assessed via simulations and through analysis of data from a mul-
ticenter clinical trial for breast cancer patients. Our proposed models have appealing
advantages over other dynamic prediction models for data with competing risks. First,
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our models are robust against violations of the PSH assumption and can directly predict
the conditional CIFs bypassing the estimation of overall survival and greatly simplify
the prediction procedure. Second, our landmark PSH supermodel enables researchers to
make predictions at a set of landmark points in one step. Third, the proposed models can
easily incorporate various types of time-dependent information using existing standard
software without computational burden.
Keywords: Competing risks; landmark method; risk prediction; time-dependent variables;
time-varying effects.
1. Introduction
An individualized risk prediction model that estimates the probability of a clinical event
dynamically using time-dependent information can enable physicians to optimize personalized
treatment strategies in real-time. For example, for an early-stage breast cancer patient who
received surgery, the physicians can adjust the approach to the subsequent chemotherapies
if knowing the risk of a distant metastasis within the next few years given the timing of
the patient’s occurrence of locoregional recurrence. Note that the occurrence of locoregional
recurrence is a time-dependent intermediate event. Other types of time-dependent information
include longitudinal measurements of biomarkers and time-varying covariate effects, which are
also crucial to the success of a risk prediction model.
Two popular approaches in dynamic prediction that received significant attention are joint
modeling (Proust-Lima and Taylor 2009, Rizopoulos 2011, Mauguen et al. 2013, Rizopoulos
et al. 2014) and landmarking (van Houwelingen 2007, van Houwelingen and Putter 2008 &
2012, Parast et al. 2012). To incorporate the time-dependent information, joint modeling
captures the processes of longitudinal and time-to-event data simultaneously whereas the
landmark method applies time-to-event modeling on patients who are still at risk at the
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updated prediction baseline, i.e., the landmark time, using the information collected up to
the landmark time. Although the joint models provide additional information from the joint
distributions, the implementation is complex and the correlation structure is difficult to specify
correctly thus often results in inaccurate prediction. By contrast, the landmark Cox model and
supermodels proposed by van Houwelingen (2007) showed significant advantages in simplicity,
flexibility, and accuracy in estimating the risk. Moreover, they become robust against model
misspecifications by avoiding the full specification of the joint distribution. These models can
easily incorporate various types of time-dependent information without using computationally
intensive estimation procedures, and the estimation can be implemented in everyday clinical
practice by using standard statistical software. Recently, landmark modeling was used in
many clinical applications (Zamboni et al. 2010, Fontein et al. 2015).
To account for data with competing events, Cortese and Andersen (2009) and Nicolaie et
al. (2013a) applied the landmark method onto the cause-specific hazards model. The disad-
vantage of this approach is that to estimate the risk from one cause we need to construct the
landmark models or supermodels based on the cause-specific hazards for all causes. For direct
modeling cause-specific risk, the Fine-Gray model (Fine and Gray 1999), pseudo-observation
approach (Klein and Andersen 2005), and direct binomial regression model (Scheike et al.
2008) are the commonly used methods, and the Fine-Gray model is the most widely used one
because the estimated risk can be easily calculated. Cortese et al. (2013) applied the landmark
method to the Fine-Gray model at a small set of fixed landmark time points, however, their
method did not assess robustness of their proposed model against violations of the propor-
tional subdistribution hazards (PSH) assumption, nor did they construct the comprehensive
landmark supermodel to estimate the risks of a sequence of prediction time points simultane-
ously. The major challenge encountered in developing a landmark model/supermodel based
on the Fine-Gray model was in constructing the landmark subset at each landmark time to
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properly account for competing events in the setting of subdistribution hazard (Nicolaie et
al. 2013a). Nicolaie et al. (2013b) developed a landmark supermodel based on the pseudo-
observations created at each landmark time point, however, additional steps are required to
calculate the risks.
In this study, we overcame the aforementioned challenges, extended the landmark method
to the Fine-Gray model, and proposed landmark PSH model and landmark PSH supermodel
for dynamic prediction in the presence of competing risks. Our proposed models can di-
rectly predict the risk for a specific cause and provide accurate prediction even when the PSH
assumption fails to hold. The landmark PSH supermodel uses smoothing techniques to ag-
gregate a set of simple landmark PSH models, allowing users to make dynamic predictions at
arbitrary landmark points using only one model, also provides a simple and explicit estimation
form to incorporate time-dependent covariates and/or time-varying covariate effects. Com-
pared to the currently available landmark dynamic prediction models for competing risks, our
proposed models are more straightforward and can be effortlessly implemented with standard
statistical software.
This paper is organized as follows. In Section 2, we first introduce notations and dynamic
predictive quantities for data with competing risks, and then review the Fine-Gray PSH
model and present our proposed landmark PSH model and supermodel. In Section 3, we
assess the performance in prediction for our proposed models and compare with the existing
methods using simulations. In Section 4, we apply the proposed models to predict the dynamic
cumulative incidences of distant metastasis based on the locoregional recurrence status and a
set of prognostic factors of breast cancer patients in a multicenter clinical trial. The discussions
are provided in Section 5.
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2. Dynamic Prediction Models
2.1. Notations and Conditional CIF
Let T and C be the failure and censoring time, respectively; ε ∈ {1, . . . , k} be the cause of
failure; and Z(·) be a p-dimensional vector of covariates, which could be time-fixed covariates
measured at the baseline or be time-dependent covariates. Here, for each subject i (i =
1, . . . , n), we assume Ci is independent of Ti and Zi(·), and refer to it as random censoring.
For right censored data, we observe an independently and identically distributed quadruplet
of {Xi = Ti ∧ Ci,∆i = I(Ti ≤ Ci),∆iεi,Zi(·)}. Suppose cause 1 is the primary event of
interest, the subdistribution function or CIF of cause 1 is defined as F1(t) = Pr(T ≤ t, ε = 1).
In dynamic prediction, the aim is to predict the conditional CIF that is the cumulative
incidence of occurring the primary event within the next w time units (also named as a
prediction window with a fixed width of w) for a subject who has not failed from any cause at
a landmark time (denoted by s) by incorporating the time-dependent information available up
to the landmark time s. The width of prediction window w depends on the clinical relevance
that defines the time interval within which the risk of having the primary event is of interest.
Then, the conditional CIF is defined as
F1,LM{s+ w|Z(s), s} = Pr{T ≤ s+ w, ε = 1|T > s,Z(s)},
where Z(s) is the covariates Z(·) whose values are measured or available at s. Using the
definition of conditional probabilities, we can rewrite the conditional CIF as
F1,LM{s+ w|Z(s), s} =
F1{s+ w|Z(s)} − F1{s|Z(s)}
S{s|Z(s)}
=
F1{s+ w|Z(s)} − F1{s|Z(s)}
1−
∑k
j=1 Fj{s|Z(s)}
,
where Fj{s|Z(s)} is the CIF for cause j and S{s|Z(s)} is the overall survival at time s.
Though existing methods can be used to estimate F1,LM{s + w|Z(s), s}, the disadvantage
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is obvious. Regression models (e.g. cause-specific hazards model and the Fine-Gray model)
are required to estimate the CIFs for all causes. In order to directly estimate the conditional
CIF without fitting models for all causes, we extend the landmark method developed by van
Houwelingen (2007) to the competing risks setting and propose a landmark PSH model which
is also robust against the misspecification of the proportional subdistribution hazards.
2.2. Fine-Gray Model
Fine and Gray (1999) proposed a regression model with respect to the subdistribution hazard
λ1(t) = lim∆t→0
1
∆t
Pr{t ≤ T ≤ t +∆t, ε = 1|T ≥ t ∪ (T ≤ t ∩ ε 6= 1)}. With time-dependent
covariates Z(t), the Fine-Gray model takes the form λ1{t|Z(t)} = λ10(t) exp{Z(t)
Tβ}; and
F1{t|Z(t)} = 1 − exp{−
∫ t
0
λ10(u) exp{Z(u)
Tβ} du}. The regression coefficients β are es-
timated through a partial likelihood approach with modified risk sets which are defined as
R(Ti) = {j : (Tj ≥ Ti)∪ (Tj ≤ Ti ∩ εj 6= 1)} for the ith individual. R(Ti) includes all subjects
who have not failed from the event of interest by time Ti.
2.3. Landmark PSH Model
To directly estimate the conditional CIF F1,LM{s + w|Z(s), s} at a given landmark time s,
we define a conditional subdistribution hazard
λ1{t|Z(s), s} = lim
∆t→0
1
∆t
Pr{t ≤ T ≤ t +∆t, ε = 1|T ≥ t ∪ (s ≤ T ≤ t ∩ ε 6= 1),Z(s)} (1)
for all t ≥ s, which is the subdistribution hazard λ1{t|Z(s)} conditional on assuming no event
occurred from any cause prior to s. It can be shown that (1) is the hazard function of the
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conditional CIF:
F1,LM{s+ w|Z(s), s} = Pr{s < T ≤ s+ w, ε = 1|T > s,Z(s)}
= 1− Pr{(T > s+ w) ∪ (s < T ≤ s + w ∩ ε 6= 1)|T > s,Z(s)}
= 1− exp(−[Λ1{s+ w|Z(s), s} − Λ1{s− |Z(s), s}])
= 1− exp
[
−
∫ s+w
s
λ1{t|Z(s), s} dt
]
,
where Λ1{·|Z(s), s} is a cumulative conditional subdistribution hazard at landmark time s.
Therefore, we propose a landmark PSH model with the form
λ1{t|Z(s), s} = λ10(t|s) exp{Z(s)
TβLM}, (2)
for s ≤ t ≤ s+ w.
To estimate the regression parameters βLM and the baseline conditional subdistribution
hazard λ10(t|s), we can simply apply the Fine-Gray model to subjects who have not yet failed
from any cause at s and ignoring the events occurring after s+w by adding an administrative
censoring at s+w. As discussed in Liu et al. (2016), under non-PSH, the Fine-Gray model with
an administrative censoring at the horizon time provides an accurate prediction of CIF at this
horizon time (but not other time points) without constructing complex procedures to estimate
time-varying effects; and the partial likelihood estimator βˆLM of βLM in model (2) is consistent
for a weighted average of possibly time-varying effect over the interval [s, s + w]. Thus, the
proposed landmark PSH model with truncation at the landmark time s and administrative
censoring at the horizon time s + w is robust to violations of the PSH assumption. The
conditional CIF can be easily estimated as
Fˆ1,LM{s+ w|Z(s), s} = 1− exp
[
− exp{Z(s)T βˆLM}{Λˆ10(s+ w)− Λˆ10(s−)}
]
,
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in which βˆLM and Λˆ10(·) are estimates calculated from the Fine-Gray model. Therefore, the
landmark PSH model provides a simple and convenient way to directly predict the conditional
CIF in dynamic prediction.
2.4. Landmark PSH Supermodel
For dynamic prediction, it is required to estimate conditional CIFs at several different land-
mark time points because the intermediate events may occur at any time point and covariate
values may also be updated during the follow up. Therefore, it is of interest to dynamically
predict the risk probabilities F1,LM{s + w|Z(s), s} with fixed width w for varying landmark
time s within an interval [s0, sL]. As discussed in van Houwelingen and Putter (2012), this
provides a dynamic prediction framework with a sliding prediction window over the specified
interval. Theoretically we can fit L+1 landmark PSH models (2) to obtain L+1 conditional
CIFs. When the number of landmark points increased dramatically, it is less practical and
computationally inefficient to fit many models separately.
Instead, we adopt the smoothing strategy of van Houwelingen (2007) and propose a landmark
PSH supermodel with the form
λ1{t|Z(s), s} = λ10(t) exp{Z(s)
TβLM(s) + γ(s)} (3)
for s0 ≤ t ≤ sL + w, which can estimate conditional CIFs at a set of landmark time points
from [s0, sL] in one step. As shown in Liu et al. (2016), βˆLM of βLM in model (2) is con-
sistent for a weighted average of β(t) over the interval [s, s + w]; so we can expect the ef-
fect of s on βLM(s) to be a continuous function and model βLM(s) as continuous functions
of s. For λ10(t|s), as the Breslow estimator showed that the dependence on s is through
βLM(s), we can also expect that the λ10(t|s) varies continuously with s and rewrite λ10(t|s)
as λ10(t|s) = λ10(t) exp{γ(s)}. Hence, the sequence of landmark PSH models at a set of
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landmark time points are combined into a supermodel via βLM(s) and γ(s) which are both
continuous functions of s. For simplicity, we can fit linear models for βLM(s) and γ(s) as fol-
lowing forms βLM(s) = βLM(s|θ) =
∑mβ
j=1 θjfj(s) and γ(s) = γ(s|η) =
∑mλ10
j=1 ηjgj(s), where
f(s) and g(s) are two sets of parametric functions of s, θ and η are vectors of parameters,
and mβ and mλ10 are the number of parameters in θ and η. Note that g(s) do not need to
contain the constant term and have the restriction of gj(s0) = 0 for all j (j = 1, . . . , mλ10)
due to identifiability of the baseline subdistribution hazard, as discussed in van Houwelingen
(2007).
To fit the landmark PSH supermodel, similar to the landmark supermodel for survival data
without competing risks (van Houwelingen 2007), we need to create an augmented dataset
which is constructed as follows: first select a set of landmark points s from the interval [s0, sL];
for each s, create a landmark subset by selecting the subjects who have not yet failed from any
cause at s and adding an administrative censoring at the prediction horizon s + w; and then
stacking all the individual landmarking subsets into a super prediction dataset. Then, model
(3) can be fitted by applying a Fine-Gray model including landmark-covariate interactions
Z(s) ∗ fj(s) to the stacked dataset.
The parameters (θ,η) can be consistently estimated by maximizing a Breslow pseudo partial
log-likelihood for tied events, because that in the stacked dataset, one subject with event time
Ti has ni = #{s : s ≤ Ti ≤ s + w, s ∈ [s0, sL]} repeated observations; and Λˆ10(t) can also
be estimated by a Breslow estimator for the cumulative subdistribution hazard (see Web
Appendix A for the details). To obtain the standard errors for the estimated parameters, a
robust sandwich estimator is required to adjust for the correlation between the risk sets which
exists because the same subject is repeatedly used when we estimate the parameters based on
the stacked dataset. Thus, the target dynamic prediction probabilities F1,LM{s + w|Z(s), s}
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have a simple and explicit estimation form, which is given by
Fˆ1,LM{s+ w|Z(s), s} = 1− exp
[
−eZ(s)
T ˆβ
LM
(s)+γˆ(s){Λˆ10(s+ w)− Λˆ10(s−)}
]
(4)
for all s ∈ [s0, sL]. Therefore, the landmark PSH supermodel can provide the prediction of
F1,LM{s+ w|Z(s), s} in any period of length w starting anywhere in the interval [s0, sL].
For implementation, before stacking all landmarking subsets into a super dataset, we need to
transform each subset into the counting process style and include time-varying IPCW weights
for the subjects experienced competing events to adjust for the random right censoring (Geskus
2011). In practice, fitting the landmark PSH supermodel in the stacked dataset requires a
software that allows for delayed entry or left truncation at s. The R function coxph() can
be used to fit model (3) and it can also provide robust sandwich covariance matrix for (θ,η)
which can be used in the significance test of the estimated regression coefficients. As discussed,
the landmark effect on λ10(t|s) is through βLM(s), so that there is a correlation between θ
and η. It is suggested to center the covariates before fitting the model (van Houwelingen and
Putter 2012).
For simplicity, we assumed that C is independent of T and Z, but, it can be generalized to
a conditional independence between C and T given Z, as discussed in the PSH model (Fine
and Gray, 1999). The dependence between C and Z can be handled by modeling C as a
function of Z in IPCW. Following the same strategy, the properties of landmark PSH model
and landmark PSH supermodel will be retained under conditional independent censoring.
2.5. Measure of Predictive Performance
To evaluate dynamic predictive performance of the proposed procedures, we adapted the time-
dependent Brier score, O/E ratio, and the area under the receiver operating characteristics
curve (AUC) in terms of predictive accuracy, calibration, and discrimination, respectively.
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The time-dependent Brier score is an estimate of the mean-squared prediction errors of the
predicted event probabilities at s+w over the observed event status for subjects who are event
free at landmark time s (Schoop et al. 2011, Cortese et al. 2013). For data with competing
risks, the expected time-dependent Brier score at landmark time s for the prediction at s+w
is defined as
BSLM(s, w) = E
(
[I(T ≤ s+ w, ε = 1)− F1,LM{s+ w|Z(s), s}]
2|T > s
)
.
When random right censoring exists, we utilized a pseudovalue-based consistent estimator
given by B̂SLM(s, w) = n˜
−1
s
∑
i∈R˜s
(
Qˆ
(i)
1,LM(s+ w|s)[1− 2Fˆ1,LM{s+ w|Zi(s), s}] + Fˆ1,LM{s+ w|Zi(s), s}
2
)
,
which was proposed by Cortese et al. (2013), where R˜s = {i : Xi > s} and n˜s is the number
of subjects in R˜s. Qˆ
(i)
1,LM(s + w|s) = n˜sFˆ1,LM(s + w|s) − (n˜s − 1)Fˆ
(i)
1,LM(s + w|s) is a jack-
knife pseudovalue for the ith subject who is still at risk at time s, where Fˆ1,LM(s + w|s) is
the nonparametric estimate of the marginal cumulative incidence Pr(T ≤ s + w|T > s), and
Fˆ
(i)
1,LM(s+ w|s) is the same estimate but is based on the data where the ith subject has been
removed.
To assess calibration, we adapted the time-dependent O/E ratio which is defined as the
observed number of main events from the landmark time point divided by the prediction
horizon time to the expected number of events estimated from the predictive model,
O/ELM(s, w) =
∑
I(s < Ti ≤ s+ w, ε = 1)∑
F1,LM{s+ w|Zi(s), s}
.
As discussed in Pfeiffer and Gail (2017), to address the right censoring, the jackknife pseu-
dovalue Qˆ
(i)
1,LM(s+ w|s) was applied, and Ô/ELM(s, w) =
∑
i∈R˜s
Qˆ
(i)
1,LM (s+w|s)
∑
i∈R˜s
Fˆ1,LM{s+w|Zi(s),s}
.
To measure discrimination capability of the landmark PSH supermodel, we followed the
work of Blanche et al. (2015) and Huang et al. (2016) to calculate the time-dependent AUC
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which is given by
AUCLM(s, w) = Pr{pii(s, w) > pij(s, w)|Di(s, w) = 1, Dj(s, w) = 0, Ti > s, Tj > s}
for a pair of subjects {i, j} both of whom have not experienced any event at the landmark time
s, where pii(s, w) = F1,LM{s + w|Zi(s), s} and Di(s, w) = I(s < Ti ≤ s + w, εi = 1). In the
presence of right censoring, an inverse probability of censoring weighting (IPCW) estimator
proposed by Blanche et al. (2015) was utilized.
3. Simulation Studies
We evaluated the performance of the proposed dynamic prediction models using simulated
data under two different settings of the nonproportional subdistribution hazards (non-PSH).
Because that nonparametric method is model-free, we used it as the reference to compare
with other model-based methods in scenarios where only categorical variables are included.
For simplicity, only two failure types were considered: type 1 failure is the primary event of
interest; type 2 failure indicates competing events. We also simulated a competing risks data
under non-PSH with a time-dependent covariate.
In the first non-PSH setting, we generated the type 1 failure times from a two-parameter
Weibull mixture distribution with the subdistribution F1,1s(t;Zi) = p(1−exp[−{λ1 exp(Ziβ1)t}
α1 ]),
where the rate parameter depends on the covariate Zi. In the second non-PSH setting, we let
the coefficient of Zi be a function of time; and the subdistribution of the primary event became
F1,2nd(t;Zi) = 1 − (1 − p[1 − exp{−(λ2t)
α2}])exp{Ziβ21+Ziβ22 ln(t+1)}. We generated the type 2
failure times from an exponential distribution Pr(Ti ≤ t|εi = 2, Zi) = 1 − exp{− exp(Ziβct)}
by taking Pr(εi = 2|Zi) = 1 − Pr(εi = 1|Zi), where βc = 0.5. Sample size of n = 1, 000 was
chosen and the data were simulated repeatedly for N = 1, 000 times. The censoring times
were generated independently from a uniform distribution.
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The performance of the proposed landmark PSH model and the landmark PSH supermodel
in dynamic prediction of the conditional CIFs using a fixed width of w at a set of landmark
points were compared with the prediction performance of the nonparametric method and the
standard PSH model. The width of prediction window w was chosen based on the distributions
of the primary event of interest (Web Figure 1).
For fitting the landmark PSH supermodel, we set up a fine grid of landmark points with
equidistant step of 0.1 from 0 to 5 for the first non-PSH setting and from 0 to 4 for the second
non-PSH setting. In both settings, we took ordinary polynomials for the basis functions as
f(s) = {1, s, s2} and g(s) = {s, s2}. Note that the landmark PSH supermodel in absence
of censoring cannot be fitted using the coxph() function in R, because that the competing
risks data cannot be transformed into the counting process format if there is no censoring;
and that the model cannot be fitted by the crr() function in R either since crr() does not
allow delayed entries. Therefore, in the absence of censoring, only the landmark PSH model
is fitted to compare with other standard approaches.
Figure 1 depicts the true and estimated conditional CIFs obtained from different approaches.
We also provided the estimates of the conditional failure probability from the landmark Cox
supermodel (van Houwelingen 2007) by treating the competing risks as random censoring. We
found that in two different non-PSH scenarios, the performance of the landmark PSH model
and the landmark PSH supermodel are as good as that of the nonparametric methods. But
the landmark Cox supermodel overestimated the risk of failure for main event in the presence
of competing risks.
For each approach we evaluated the prediction errors in the dynamic conditional CIFs by
estimating time-dependent Brier scores, and we used a 3-fold cross-validation to correct for
possible overfitting. Web Table 1 presents averaged estimates of the cross-validated time-
dependent Brier score and its empirical standard deviation. To quantify the improvement of
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predictive accuracy for the proposed landmark PSH model and supermodel to the standard
PSH model under nonproportional hazards, we utilized a relative increment (or reduction)
of prediction errors by treating the nonparametric estimates as the reference. The relative
increment of prediction errors are presented in Figure 2. As expected, in both non-PSH
settings the predictive accuracy of the landmark PSH model was almost the same as that
obtained from the nonparametric method. As compared with the landmark PSH model or
the nonparametric method, the landmark PSH supermodel has slightly lower accuracy, yet
the differences in prediction errors are negligible.
To further evaluate predictive performance of the proposed landmark PSH supermodel for
data with time-dependent covariates, we added Zi(t) into the second non-PSH setting using
the simulation strategy introduced in Huang et al. (2016) (see Web Appendix B for details).
We chose a prediction window of w = 0.4 and sample size of n = 5, 000 to calculate the
3-fold cross-validated time-dependent O/E ratio, Brier score, and AUC for the landmark PSH
supermodel and compared it with the landmark Cox supermodel. To fit the supermodels, we
selected landmark time points from 0 to 4 with a step of 0.1, and used the same quadratic basis
function f(s) and g(s) for Zi(t) because that only the effect of Zi(t) depends on landmark
s in the Wald test. Table 1 provides averaged estimates of the O/E ratio, Brier score, and
AUC with the corresponding empirical standard errors from 1, 000 simulated data sets. The
landmark PSH supermodel showed a good predictive performance in terms of calibration,
predictive accuracy, and discrimination.
4. Application
To illustrate the application of our proposed landmark PSH supermodel in prediction of the
conditional cumulative incidence probabilities for a moving (or dynamic) time interval with
a fixed width, we used the data from a multicenter phase III clinical trial for breast cancer
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patients with estrogen receptor positive and historically nodes negative (Fisher et al. 1997). In
this trial, 2,363 patients were randomly assigned to receive one of the following three regimens:
tamoxifen 10mg daily for 5 years, tamoxifen 10mg daily for 5 years plus metrotrexate (M) and
Fluorouracil (F), and tamoxifen 10mg daily for 5 years plus M, F, and cyclophosphamide (C);
denoted TAM, TAM+MF, and TAM+CMF, respectively for simplicity. The median follow-up
time was 11.2 years.
Among the 2,272 clinically eligible patients who were followed, 241 developed distant metas-
tasis, 127 died due to other causes before distant metastasis could occur, and the remaining
1,904 were censored due to withdrawal of the study, lost to follow up, or event-free on or before
the analysis cutoff date. In analyses, the censoring cases were treated as random noninforma-
tive censoring where the justification is described in Web Appendix C. For early stage breast
cancer patients after surgery, development of locoregional recurrence (LRR) is an important
prognostic clinical event affecting the risk of distant metastasis. In this data, 15.1% of the
patients developed LRR before progressing to distant metastasis; but only 6.6% patients ex-
perienced LRR before death. Our main interest in this application is to dynamically predict
the risk of distant metastasis within the subsequent 3-years for a breast cancer patient, based
on her LRR status measured during follow-up and other prognostic covariates measured at
baseline, including the treatment (TAM, TAM+MF, or TAM+CMF), surgery type (lumpec-
tomy plus radiation therapy [L+XRT] vs. mastectomy), age at the study entry (< 50 vs.
≥ 50 years old), clinical tumor size (≤ 2 vs. > 2 cm), and tumor grade (well, moderate, and
poor). We also compared the dynamic 3-year fixed width probabilities of distant metastasis
and death based on a patient’s LRR history.
Web Figure 2(a) shows that the estimated CIFs for both distant metastasis and death in
which the maximum event time around 13 years. Web Figure 2(b) depicts the estimated CIF
of LRR. There were only a few random censoring events occurred during the first 10 years of
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follow-up (figure not shown). Thus, we chose the range of landmark points from 0 to 10 years
and prediction window with a fixed width of 3-years. To fit a landmark PSH supermodel to
this dataset, we took 51 equally spaced landmark points s (0 ≤ s ≤ 10) and set the basis
functions for βLM(s) and γ(s) as βLM(s) = θ1+θ2s+θ3s
2 and γ(s) = η1s+η2s
2, respectively.
The frequencies of distant metastasis and death in each of the landmark sub-dataset for
s = 0, 1, . . . , 10 years are shown in Web Figure 2(c).
We began our analysis using the backward selection procedure to select those covariates of
which the effects were dependent on the landmark points. We tested the landmark-covariate
interactions for each covariate via the Wald test based on the robust covariance matrix of the
estimated coefficients from the landmark PSH supermodel. We found that for distant metas-
tasis, the effects of TAM+MR and age were significantly dependent on the landmark points,
whereas for death, only the effect of LRR status was dependent on the landmark points. The
estimated coefficient and the corresponding robust standard error for a given prognostic factor
are summarized in Table 2. Multivariate Wald tests for the baseline parameters (η1, η2) were
significant for both distant metastasis and death, indicating that the baseline subdistribution
hazard also depended on the choice of landmark points.
Given different LRR status ( including no LRR developed over the course of study, with the
first LRR occurred at 3, 5, and 7 years) and different treatment regimens (TAM, TAM+MF, or
TAM+CMF), Figure 3 depicts the predicted dynamic 3-year fixed width cumulative incidences
of distant metastasis and death with the associated bootstrap 95% confidence intervals for
patients younger than 50 years old with poorly differentiated tumors, tumor size larger than
2cm and treated by L+XRT. If a patient did not develop LRR, the risk of having distant
metastasis within the subsequent 3 years is very close to the risk of death in any treatment
group. However, if the patient occurred LRR, she would have a much higher risk of developing
distant metastasis compared to the risk of death, especially for TAM+MF treatment group.
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Similar trends were obtained for patients if they experience the first LRR at 3, 5, and 7 years,
respectively.
We compared the risk prediction performance of our proposed landmark PSH supermodel
against the landmark Cox supermodel. The fitted landmark Cox supermodel is summarized in
Web Table 2. In addition to measure the time-dependent O/E ratio, Brier score, and AUC at
a selected set of landmark time points with bootstrap standard errors with B = 500, we also
calculated the squared bias (Bias2) for both models. As results shown in Table 3, the landmark
PSH supermodel is well-calibrated compared to the landmark Cox supermodel which tends to
underestimate the risk of event with larger O/E ratios. Although two models provide similar
Brier score results, the Cox supermodel has notably larger squared bias in predictive accuracy,
which indicates that the Brier score is dominated by the Bernoulli variation of the outcome
not by the squared bias in this application data, so leads to a limited variation in Brier score
between two models. Because of the two models have the similar model form (Table 2 and
Web Table 2), the difference of AUCs are limited in this application example.
To demonstrate an additional value that dynamic prediction provides, we compared the
performance of the landmark PSH supermodel that dynamically incorporated LRR status at
each landmark time to the PSH model that simply used LRR status as a predictor to predict
the CIFs at the horizon time. Results are summarized in Web Table 3. Apparently, the
landmark PSH supermodel outperformed the PSH model in terms of both calibration and
predictive accuracy.
5. Discussion
In this study, we developed dynamic prediction models for data containing competing risks
by extending the landmark approach to the Fine-Gray model. The resulting landmark PSH
model and the supermodel can be used to directly predict the dynamic cumulative incidences
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for the occurrence of a specific event within a given prediction window of a fixed width through
incorporating all available information up to the landmark time under the condition that the
patient has not failed at the landmark time.
Our proposed models have several advantageous features over the currently available meth-
ods in predicting the dynamic cumulative inferences. First, our landmark PSH models can
provide accurate estimates even when covariate effects are potentially time-varying and vio-
late the PSH assumption whereas the model developed by Cortese et al. (2013) will lead to
biased estimate under violations of the PSH assumption even after incorporating the land-
mark method into the Fine-Gray model. Second, unlike the Fine-Gray model which does
not allow the use of internal time-dependent covariate in prediction of the CIF (Kalbfleisch
and Prentice 2002, Beyersmann and Schumacher 2008), the landmark PSH models can incor-
porate both internal and external time-dependent information through a simple model form
that bypasses modeling the covariate changing process and the time-to-event outcome pro-
cess. The landmark method provides a simpler and explicit form of estimates and it is much
easier to incorporate intermediate events and/or time-dependent covariates as compared with
the multistate model and joint models that are more complicated and prone to overfitting.
Furthermore, the proposed landmark PSH supermodel is more straightforward and simpler
to implement using the existing standard software packages. In contrast with the landmark
supermodel based on the cause-specific hazards (Nicolaie et al. 2013a), our landmark PSH su-
permodel predicts the conditional CIFs only in one step and provides a direct interpretation of
the landmark-specific effects on the predictive probabilities. Compared with the landmark su-
permodel based on the pseudo-observations (Nicolaie et al. 2013b), our supermodel also shows
simplicity in computation whereas the GEE-based method used in pseudo-observations would
have convergence issues for large sample size especially when dealing with many landmark
points of interest.
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We evaluated the prediction performance of our proposed models through simulations and
compared to other existing methods. We determined how closely the estimated conditional
CIFs would approximate the true probabilities for our models, which is the first of its kind
done in this area of study. We also evaluated the landmark supermodel in competing risks
data from the perspectives of calibration, predictive accuracy, and discrimination capabilities
by utilizing the time-dependent O/E ratios, Brier scores and AUCs. The simulation results
showed that our models performed well in prediction after incorporating time-fixed and time-
dependent covariates even when the PSH assumption was violated.
In the landmark PSH supermodel, we assume that the effect of s on baseline hazards λ10(t|s)
was an additive effect. As discussed in van Houwelingen (2007), this assumption will hold if
the follow-up is not too long or the effect of covariates is not too large. If we choose an optimal
width w for the prediction window and a suitable range [s0, sL] for the landmark time points,
the landmark PSH supermodel can provide a correct approximation for the conditional CIF
at time s + w for any s ∈ [s0, sL]. An alternative method is to fit a stratified landmark
PSH supermodel by applying a Fine-Gray model with the landmark-covariate interactions
Z(s) ∗ fj(s) to the stacked dataset with stratification on s, which estimates the baseline
conditional subdistribution hazard for each s.
Note that in the presence of time-dependent covariates, if the covariate values vary too often
and too much over time, the estimated covariate effects could be attenuated in the proposed
models and subsequently lead to biased estimation of the conditional CIF. This is also shown
in our simulation result for data with a time-dependent covariate. To adjust for this issue,
which was also discussed by van Houwelingen and Putter (2012), we will explore a set of
suitable landmark time points and use an additional monotonically decreasing function to
model the attenuation process of the covariate effects as future work.
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Figure 1 – Predicted conditional cumulative incidences over w years (averaged over
1000 simulations) at landmark points. The 1st non-PSH setting with (α1, λ1, β1) =
(3.2, 0.18,−0.81) and the 2nd non-PSH setting with (α2, λ2, β21, β22) = (3.2, 0.12, 0.8, 0.3).
Z is Bernoulli(0.5) variant; and p = 0.3, which produced about 30% main events at Zi = 0
when there was no censoring. Black curves: the Z = 1 group; gray curves: the Z = 0
group. True: underlying true conditional CIFs. NP: nonparametric method; PSH: the
standard PSH model; LM-PSH; the landmark PSH model; LM-PSH-Super: the landmark
PSH supermodel; LM-Cox-Super: the landmark Cox supermodel, in which the y-axis is
the conditional failure probabilities for main event.
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Figure 2 – Relative increment of prediction errors (and their standard deviation) at
landmark points. The prediction errors were cross-validated (3-fold) estimates for the
time-dependent Brier scores, where w = 3 for the 1st non-PSH setting with (α1, λ1, β1) =
(3.2, 0.18,−0.81) and w = 2 for the 2nd non-PSH setting with (α2, λ2, β21, β22) =
(3.2, 0.12, 0.8, 0.3). Z is Bernoulli(0.5) variant; and p = 0.3, which produced about 30%
main events at Zi = 0 when there was no censoring. NP: nonparametric method; PSH: the
standard PSH model; LM-PSH; the landmark PSH model; LM-PSH-Super: the landmark
PSH supermodel.
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Figure 3 – The predicted 3-year fixed width conditional cumulative incidences of distant
metastasis (blue solid lines) and death (yellow dashed lines) with the associated bootstrap
95% confidence intervals (shaded areas) for different landmark time points, for patients
younger than 50-years old with poor tumor grade, tumor size larger than 2cm and treated
with lumpectomy in each of the treatment groups and with the first locoregional recurrence
occurred at none, 3 years, 5 years and 7 years.
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Table 1 – Cross-validated (3-fold) estimates of the time-dependent O/E ratio of observed
number of events (O) to expected number of events (E), Brier score and AUC with the
corresponding standard errors (se) for the landmark PSH supermodel (LM-PSH-Super)
and the landmark Cox supermodel (LM-Cox-Super) in the 2nd non-PSH setting with
time-fixed and time-dependent covariates. All entries are multiplied by 100.
LM-PSH-Super
Landmark O/E (se) Brier score (se) AUC (se)
2.4 103.001 (15.356) 4.237 (11.421) 67.285 (5.805)
2.6 101.166 (14.050) 5.511 (11.836) 68.113 (4.545)
2.8 99.082 (12.702) 6.906 (11.135) 70.396 (3.749)
3.0 93.396 (12.686) 9.799 (11.981) 74.628 (3.966)
3.2 95.898 (14.165) 13.664 (12.298) 74.143 (4.253)
3.4 96.497 (13.877) 16.807 (11.093) 73.681 (4.343)
3.6 96.486 (13.257) 19.360 (9.965) 73.741 (4.618)
LM-Cox-Super
Landmark O/E (se) Brier score (se) AUC (se)
2.4 70.687(44.813) 37.405 (36.391) 60.853 (8.206)
2.6 65.017 (45.379) 41.575 (37.761) 60.820 (8.270)
2.8 61.776 (44.256) 43.415 (38.241) 61.910 (9.160)
3.0 56.393 (41.745) 47.426 (37.717) 63.376 (11.370)
3.2 59.426 (42.258) 48.259 (34.891) 62.858 (11.656)
3.4 65.245 (39.696) 44.926 (30.568) 63.480 (11.737)
3.6 66.728 (34.844) 43.217 (25.862) 63.185 (11.674)
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Table 2 – Estimated regression parameters of the landmark PSH supermodel for distant
metastasis and death. s is landmark time; η1 and η2 are baseline parameters defined in
Section 2.4.
Distant metastasis Death
Covariate βˆ se(βˆ) βˆ se(βˆ)
Treatment
TAM + MF vs. TAM Constant -1.091 0.331 -0.312 0.238
s 0.482 0.160
s2 -0.050 0.017
TAM + CMF vs. TAM Constant -0.470 0.170 0.160 0.219
Age
≥ 50 vs. < 50 Constant -0.540 0.257 1.057 0.218
s 0.407 0.135
s2 -0.035 0.015
Surgery type
Mastectomy vs. L + XRT Constant 0.424 0.144 -0.115 0.189
Clinical tumor size
> 2 vs. ≤ 2 cm Constant 0.284 0.141 0.334 0.196
Tumor grade
Moderate vs. Well Constant 0.221 0.179 0.104 0.221
Poor vs. Well Constant 0.752 0.189 0.124 0.258
Localregional recurrence status
Constant 2.315 0.237 3.575 1.230
s -0.492 0.582
s2 0.008 0.056
Baseline parameters
η1 s -0.400 0.088 -0.001 0.014
η2 s
2 0.035 0.009 0.002 0.001
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Table 3 – Estimates of the time-dependent O/E ratio of the observed number of events
(O) to the expected number of events (E), squared bias (Bias2), Brier score and AUC
(with standard errors from bootstrap with B=500) at a selected set of landmark time
points for distant metastasis and death. LM-PSH-Super: the landmark PSH supermodel;
LM-Cox-Super: the landmark Cox supermodel. All entries are multiplied by 100.
Landmark LM-PSH-Super
(years) O/E (se) Bias2 (se) Brier score (se) AUC (se)
1 102.055 (10.042) 0.00008 (0.003) 4.237 (0.395) 66.174 (2.943)
Distant 3 98.609 (9.938) 0.00003 (0.002) 3.854 (0.370) 68.260 (3.156)
Metastasis 5 99.134 (12.911) 0.000007 (0.002) 2.856 (0.364) 74.688 (3.266)
7 99.771 (15.288) 0.0000003 (0.002) 2.070 (0.308) 67.821 (4.718)
1 100.754 (19.187) 0.0000008 (0.0008) 1.206 (0.224) 62.136 (6.003)
Death 3 97.965 (16.038) 0.000009 (0.0008) 1.439 (0.228) 76.705 (4.398)
5 100.202 (16.506) 0.0000002 (0.002) 1.913 (0.308) 64.165 (4.530)
7 100.208 (14.454) 0.0000003 (0.002) 2.553 (0.357) 63.816 (4.282)
Landmark LM-Cox-Super
(years) O/E (se) Bias2 (se) Brier score (se) AUC (se)
1 101.099 (9.949) 0.00002 (0.003) 4.265 (0.397) 66.175 (2.953)
Distant 3 124.565 (12.581) 0.007 (0.008) 3.881 (0.382) 68.373 (3.151)
Metastasis 5 111.843 (14.550) 0.001 (0.004) 2.885 (0.371) 74.639 (3.264)
7 120.795 (18.517) 0.001 (0.004) 2.097 (0.316) 67.917 (4.692)
1 103.829 (19.861) 0.00002 (0.0009) 1.241 (0.228) 62.291 (6.009)
Death 3 110.630 (18.211) 0.0002 (0.001) 1.478 (0.235) 76.497 (4.391)
5 106.203 (17.515) 0.0001 (0.002) 1.947 (0.314) 64.295 (4.539)
7 109.095 (15.754) 0.0005 (0.003) 2.585 (0.363) 64.924 (4.217)
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